Escala Medical
Tel Aviv, Israel· Est.
Incision‑free, outpatient POP repair device with FDA clearance and rapid patient recovery.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $12M
AI Company Overview
Incision‑free, outpatient POP repair device with FDA clearance and rapid patient recovery.
Women’s HealthUrogynaecologyPelvic Organ Prolapse
Technology Platform
A needle‑guided, incision‑free delivery system that places a biocompatible anchor within pelvic ligaments to restore organ support in minutes.
Opportunities
Expansion into European markets and broader urogynaecology indications could drive significant revenue growth.
Risk Factors
Adoption may be limited by physician familiarity with traditional surgical techniques and competitive mesh‑based devices.
Competitive Landscape
Key competitors include mesh‑based POP systems (Obtryx, Elevate) and suturing devices; Escala differentiates with a truly incision‑free, rapid‑recovery platform.